Published in Viral Immunol on May 01, 2014
Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs. Front Immunol (2015) 0.90
Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells. Front Immunol (2015) 0.81
iTRAQ-based quantitative proteomics reveals important host factors involved in the high pathogenicity of the H5N1 avian influenza virus in mice. Med Microbiol Immunol (2016) 0.76
The Effect of Oseltamivir on the Disease Progression of Lethal Influenza A Virus Infection: Plasma Cytokine and miRNA Responses in a Mouse Model. Dis Markers (2016) 0.75
PA-X-associated early alleviation of the acute lung injury contributes to the attenuation of a highly pathogenic H5N1 avian influenza virus in mice. Med Microbiol Immunol (2016) 0.75
Cold stress aggravates inflammatory responses in an LPS-induced mouse model of acute lung injury. Int J Biometeorol (2015) 0.75
Toll-like receptor control of the adaptive immune responses. Nat Immunol (2004) 19.15
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med (2006) 14.21
Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol (2006) 12.29
Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 11.24
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40
Cell type-specific involvement of RIG-I in antiviral response. Immunity (2005) 9.37
Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A (2004) 9.00
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature (2006) 6.46
Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe (2007) 5.46
The pathology of influenza virus infections. Annu Rev Pathol (2008) 5.37
Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol (2001) 4.90
Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res (2005) 4.41
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest (2008) 4.30
CD8+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol (2000) 4.22
Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol (2006) 4.00
Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science (2009) 3.88
A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol (2007) 3.65
Cell-mediated protection in influenza infection. Emerg Infect Dis (2006) 3.62
RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell (2010) 3.59
CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J Immunol (2006) 2.99
Distinct pathogenesis of hong kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J Virol (2000) 2.84
Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol (2004) 2.79
Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol (2007) 2.73
CD8 T cell responses to infectious pathogens. Annu Rev Immunol (2001) 2.68
Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A (2007) 2.63
Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses. Antimicrob Agents Chemother (2001) 2.21
Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase. Shock (2010) 1.82
Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am J Respir Crit Care Med (2006) 1.77
Influenza vaccine--outmaneuvering antigenic shift and drift. N Engl J Med (2004) 1.72
Cytokines in the pathogenesis of influenza. Vet Microbiol (2000) 1.70
Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection. J Virol (2012) 1.61
The role of neutrophils during mild and severe influenza virus infections of mice. PLoS One (2011) 1.61
Respiratory epithelial cells in innate immunity to influenza virus infection. Cell Tissue Res (2010) 1.57
Host response to influenza virus: protection versus immunopathology. Curr Opin Immunol (2010) 1.55
Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J Virol (2008) 1.51
Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells. J Immunol (2004) 1.43
Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung. Mucosal Immunol (2012) 1.30
Interleukin-6: from an inflammatory marker to a target for inflammatory diseases. Trends Immunol (2012) 1.28
Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep (2013) 1.17
Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors. Crit Care Med (2009) 1.10
Airway immune homeostasis and implications for influenza-induced inflammation. Trends Immunol (2011) 1.03
Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09. J Clin Virol (2013) 1.01
TNF soluble receptor and antiserum against TNF enhance lipopolysaccharide fever in mice. Am J Physiol (1995) 1.00
Responses of mouse airway epithelial cells and alveolar macrophages to virulent and avirulent strains of influenza A virus. Viral Immunol (2011) 0.99
Highly pathological influenza A virus infection is associated with augmented expression of PD-1 by functionally compromised virus-specific CD8+ T cells. J Virol (2013) 0.86
Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation. J Exp Med (2005) 2.59
CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza. Immunol Rev (2006) 2.49
Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. J Clin Invest (2012) 1.95
Persistent depots of influenza antigen fail to induce a cytotoxic CD8 T cell response. J Immunol (2007) 1.68
Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine (2005) 1.31
Unique ability of activated CD4+ T cells but not rested effectors to migrate to non-lymphoid sites in the absence of inflammation. J Biol Chem (2006) 1.15
CD8+ T cells responding to influenza infection reach and persist at higher numbers than CD4+ T cells independently of precursor frequency. Clin Immunol (2004) 1.07
Regulation of memory CD4 T cells: generation, localization and persistence. Adv Exp Med Biol (2002) 1.02
Rat injury model under controlled field-relevant primary blast conditions: acute response to a wide range of peak overpressures. J Neurotrauma (2013) 0.98
Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-α-reactive CD4 T cells in A/J mice. Clin Immunol (2012) 0.94
Control of early Theiler's murine encephalomyelitis virus replication in macrophages by interleukin-6 occurs in conjunction with STAT1 activation and nitric oxide production. J Virol (2012) 0.91
Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinase. J Med Chem (2006) 0.89
IRF3 helps control acute TMEV infection through IL-6 expression but contributes to acute hippocampus damage following TMEV infection. Virus Res (2013) 0.84
IRF3 polymorphisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages. Virology (2011) 0.84
3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo models. J Med Chem (2012) 0.81
Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors. Prostate (2002) 0.80
Expression, purification, and initial characterization of a recombinant form of plant PEP-carboxylase kinase from CAM-induced Mesembryanthemum crystallinum with enhanced solubility in Escherichia coli. Protein Expr Purif (2003) 0.80
Chronic renal disease in a captive two-toed sloth (Choloepus didactylus) with concurrent hepatocellular carcinoma. J Zoo Wildl Med (2014) 0.75
Neuromuscular electrical stimulation during task-oriented exercise improves arm function for an individual with proximal arm dysfunction after stroke. Am J Phys Med Rehabil (2007) 0.75